Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials
L Wang, PJ Hong, C May, Y Rehman, Y Oparin… - Bmj, 2021 - bmj.com
Objective To determine the benefits and harms of medical cannabis and cannabinoids for
chronic pain. Design Systematic review and meta-analysis. Data sources MEDLINE …
chronic pain. Design Systematic review and meta-analysis. Data sources MEDLINE …
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis
Background Medicinal cannabinoids, including medicinal cannabis and pharmaceutical
cannabinoids and their synthetic derivatives, such as tetrahydrocannabinol (THC) and …
cannabinoids and their synthetic derivatives, such as tetrahydrocannabinol (THC) and …
[HTML][HTML] Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations …
Background Cannabis use is common, especially among young people, and is associated
with risks for various health harms. Some jurisdictions have recently moved to …
with risks for various health harms. Some jurisdictions have recently moved to …
Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline
JW Busse, P Vankrunkelsven, L Zeng, AF Heen… - bmj, 2021 - bmj.com
Clinical question What is the role of medical cannabis or cannabinoids for people living with
chronic pain due to cancer or non-cancer causes? Current practice Chronic pain is common …
chronic pain due to cancer or non-cancer causes? Current practice Chronic pain is common …
Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials
Cannabinoids, cannabis, and cannabis-based medicines (CBMs) are increasingly used to
manage pain, with limited understanding of their efficacy and safety. We summarised …
manage pain, with limited understanding of their efficacy and safety. We summarised …
Cannabis-based medicines and medical cannabis for chronic neuropathic pain
F Petzke, T Tölle, MA Fitzcharles, W Häuser - CNS drugs, 2022 - Springer
Neuropathic pain represents a broad category of pain syndromes that include a wide variety
of peripheral and central disorders. The overall prevalence of neuropathic pain in the …
of peripheral and central disorders. The overall prevalence of neuropathic pain in the …
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
P Alves, C Amaral, N Teixeira… - Pharmacological …, 2020 - Elsevier
Cannabis is the most used illicit drug worldwide and its medicinal use is under discussion,
being regulated in several countries. However, the psychotropic effects of Δ 9 …
being regulated in several countries. However, the psychotropic effects of Δ 9 …
Clinical updates on phantom limb pain
Methods: This review aims to provide an interdisciplinary overview of recent evidence-based
and clinical knowledge. Results: The scientific evidence for best practice is weak and …
and clinical knowledge. Results: The scientific evidence for best practice is weak and …
A review of scientific evidence for THC: CBD oromucosal spray (nabiximols) in the management of chronic pain
MA Überall - Journal of pain research, 2020 - Taylor & Francis
The 20% prevalence of chronic pain in the general population is a major health concern
given the often profound associated impairment of daily activities, employment status, and …
given the often profound associated impairment of daily activities, employment status, and …
Medical cannabis treatment for chronic pain: outcomes and prediction of response
J Aviram, D Pud, T Gershoni… - … Journal of Pain, 2021 - Wiley Online Library
Background Although studied in a few randomized controlled trials, the efficacy of medical
cannabis (MC) for chronic pain remains controversial. Using an alternative approach, this …
cannabis (MC) for chronic pain remains controversial. Using an alternative approach, this …